1S3E
Crystal structure of MAOB in complex with 6-hydroxy-N-propargyl-1(R)-aminoindan
1S3E の概要
| エントリーDOI | 10.2210/pdb1s3e/pdb |
| 関連するPDBエントリー | 1S2Q 1S2Y 1S3B |
| 分子名称 | Amine oxidase [flavin-containing] B, FLAVIN-ADENINE DINUCLEOTIDE, (3R)-3-(PROP-2-YNYLAMINO)INDAN-5-OL, ... (4 entities in total) |
| 機能のキーワード | human monoamine oxidase, inhibitor binding, rasagiline, enantioselectivity, flavin, oxidoreductase |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Mitochondrion outer membrane; Single-pass type IV membrane protein; Cytoplasmic side: P27338 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 119621.04 |
| 構造登録者 | Binda, C.,Hubalek, F.,Li, M.,Herzig, Y.,Sterling, J.,Edmondson, D.E.,Mattevi, A. (登録日: 2004-01-13, 公開日: 2004-03-30, 最終更新日: 2024-11-20) |
| 主引用文献 | Binda, C.,Li, M.,Herzig, Y.,Sterling, J.,Edmondson, D.E.,Mattevi, A. Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the N-Propargylaminoindan Class. J.Med.Chem., 47:1767-1774, 2004 Cited by PubMed Abstract: Monoamine oxidase B (MAO B) is an outer mitochondrial membrane enzyme that catalyzes the oxidation of arylalkylamine neurotransmitters. The crystal structures of MAO B in complex with four of the N-propargylaminoindan class of MAO covalent inhibitors (rasagiline, N-propargyl-1(S)-aminoindan, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan) have been determined at a resolution of better than 2.1 A. Rasagiline, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan adopt essentially the same conformation with the extended propargyl chain covalently bound to the flavin and the indan ring located in the rear of the substrate cavity. N-Propargyl-1(S)-aminoindan binds with the indan ring in a flipped conformation with respect to the other inhibitors, which causes a slight movement of the Tyr326 side chain. Four ordered water molecules are an integral part of the active site and establish H-bond interactions to the inhibitor atoms. These structural studies may guide future drug design to improve selectivity and efficacy by introducing appropriate substituents on the rasagiline molecular scaffold. PubMed: 15027868DOI: 10.1021/jm031087c 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.6 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






